Nektar Therapeutics (NKTR)
1.32
0.00 (0.00%)
USD |
NASDAQ |
Apr 26, 16:00
1.32
0.00 (0.00%)
After-Hours: 20:00
Nektar Therapeutics Free Cash Flow: -193.47M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -193.47M |
| September 30, 2023 | -204.40M |
| June 30, 2023 | -245.32M |
| March 31, 2023 | -269.40M |
| December 31, 2022 | -309.68M |
| September 30, 2022 | -408.90M |
| June 30, 2022 | -429.91M |
| March 31, 2022 | -440.32M |
| December 31, 2021 | -427.65M |
| September 30, 2021 | -370.60M |
| June 30, 2021 | -321.12M |
| March 31, 2021 | -321.53M |
| December 31, 2020 | -320.54M |
| September 30, 2020 | -349.05M |
| June 30, 2020 | -368.43M |
| March 31, 2020 | -347.40M |
| December 31, 2019 | -354.97M |
| September 30, 2019 | -352.31M |
| June 30, 2019 | -351.58M |
| March 31, 2019 | 670.88M |
| December 31, 2018 | 703.98M |
| September 30, 2018 | 747.42M |
| June 30, 2018 | 912.79M |
| March 31, 2018 | -104.89M |
| December 31, 2017 | -90.09M |
| Date | Value |
|---|---|
| September 30, 2017 | -62.36M |
| June 30, 2017 | -182.36M |
| March 31, 2017 | -136.74M |
| December 31, 2016 | -123.42M |
| September 30, 2016 | -145.94M |
| June 30, 2016 | -136.24M |
| March 31, 2016 | -171.86M |
| December 31, 2015 | -84.28M |
| September 30, 2015 | -35.21M |
| June 30, 2015 | -63.94M |
| March 31, 2015 | -22.92M |
| December 31, 2014 | -151.98M |
| September 30, 2014 | -72.55M |
| June 30, 2014 | -45.94M |
| March 31, 2014 | -71.00M |
| December 31, 2013 | -42.62M |
| September 30, 2013 | -145.76M |
| June 30, 2013 | -155.20M |
| March 31, 2013 | -142.63M |
| December 31, 2012 | -140.34M |
| September 30, 2012 | -131.77M |
| June 30, 2012 | -125.34M |
| March 31, 2012 | -140.96M |
| December 31, 2011 | -123.46M |
| September 30, 2011 | -68.71M |
Free Cash Flow Range, Past 5 Years
-440.32M
Minimum
Mar 2022
-193.47M
Maximum
Dec 2023
-336.14M
Average
-349.05M
Median
Sep 2020
Free Cash Flow Benchmarks
| Stereotaxis Inc | -9.505M |
| Vanda Pharmaceuticals Inc | 12.42M |
| Cara Therapeutics Inc | -94.45M |
| Marinus Pharmaceuticals Inc | -118.12M |
| DiaMedica Therapeutics Inc | -18.75M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -47.05M |
| Cash from Investing (Quarterly) | 17.38M |
| Cash from Financing (Quarterly) | 0.012M |
| Free Cash Flow Per Share (Quarterly) | -0.2475 |
| Free Cash Flow to Equity (Quarterly) | -47.28M |
| Free Cash Flow to Firm (Quarterly) | -44.94M |
| Free Cash Flow Yield | -77.14% |